Bank of America’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-591,834
| Closed | -$113K | – | 7652 |
|
|
2025
Q3 | $113K | Sell |
591,834
-36,096
| -6% | -$43.2K | ﹤0.01% | 6548 |
|
|
2025
Q2 | $1.07M | Sell |
627,930
-70,338
| -10% | -$119K | ﹤0.01% | 5260 |
|
|
2025
Q1 | $1.1M | Sell |
698,268
-114,042
| -14% | -$193K | ﹤0.01% | 5151 |
|
|
2024
Q4 | $1.45M | Buy |
812,310
+812,302
| +10,153,775% | +$2.59M | ﹤0.01% | 4722 |
|
|
2024
Q3 | $48 | Hold |
8
| – | – | ﹤0.01% | 7843 |
|
|
2024
Q2 | $42 | Hold |
8
| – | – | ﹤0.01% | 7867 |
|
|
2024
Q1 | $68 | Hold |
8
| – | – | ﹤0.01% | 7426 |
|
|
2023
Q4 | $53 | Hold |
8
| – | – | ﹤0.01% | 7491 |
|
|
2023
Q3 | $25 | Hold |
8
| – | – | ﹤0.01% | 7558 |
|
|
2023
Q2 | $22 | Sell |
8
-2,162
| -100% | -$6.34K | ﹤0.01% | 7512 |
|
|
2023
Q1 | $6.45K | Buy |
2,170
+1,156
| +114% | +$3.4K | ﹤0.01% | 7012 |
|
|
2022
Q4 | $2.56K | Buy |
1,014
+1,006
| +12,575% | +$2.89K | ﹤0.01% | 7187 |
|
|
2022
Q3 | $0 | Sell |
8
-8,656
| -100% | -$22.8K | ﹤0.01% | 7935 |
|
|
2022
Q2 | $27K | Sell |
8,664
-2,950
| -25% | -$16.5K | ﹤0.01% | 7083 |
|
|
2022
Q1 | $72K | Buy |
11,614
+3,420
| +42% | +$30.1K | ﹤0.01% | 7015 |
|
|
2021
Q4 | $116K | Buy |
8,194
+1,258
| +18% | +$14K | ﹤0.01% | 6813 |
|
|
2021
Q3 | $55K | Buy |
6,936
+2,917
| +73% | +$46.4K | ﹤0.01% | 7001 |
|
|
2021
Q2 | $115K | Buy |
4,019
+3,199
| +390% | +$93K | ﹤0.01% | 6438 |
|
|
2021
Q1 | $24K | Buy |
820
+812
| +10,150% | +$18.9K | ﹤0.01% | 6841 |
|
|
2020
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 7154 |
|
|
2020
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 6962 |
|
|
2020
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 6904 |
|
|
2020
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 6946 |
|
|
2019
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 7161 |
|
|
2019
Q3 | $0 | Buy |
+8
| New | +$20 | ﹤0.01% | 7309 |
|
|
2018
Q2 | – | Sell |
-125
| Closed | – | – | 7137 |
|
|
2018
Q1 | $0 | Buy |
+125
| New | +$521 | ﹤0.01% | 7156 |
|
Bank of America's EPIX Position: Q4 2025 in Review
Bank of America sold out of ESSA Pharma (EPIX) in Q4 2025, closing a stake of 591,834 shares — an estimated $113K sold.
Bank of America first reported a position in EPIX in Q1 2018 and held it in 26 quarters. The position peaked at $1.45M in Q4 2024. 0 funds tracked by Wall St. Rank hold EPIX as of Q4 2025.
- Bank of America reported no remaining ESSA Pharma position as of Q4 2025 after selling out during the quarter.
- Bank of America sold 591,834 ESSA Pharma shares in Q4 2025, an estimated $113K.
- Bank of America first reported a position in ESSA Pharma in Q1 2018 and held it in 26 quarters.
- Bank of America's ESSA Pharma position peaked at $1.45M in Q4 2024.
- 0 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2025.
Based on Bank of America's 13F filing for Q4 2025, filed 17 Feb 2026.